$VNDA Headlines What are hedge funds buying these days?

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2013 at 4:12 PM

$VNDA Headlines

What are hedge funds buying these days? 11:52 a.m. June 14, 2013 - Insider Monkey
3 longs and 3 shorts to watch 2:22 p.m. June 12, 2013 - The Trading Deck
Vanda Pharma shares up on positive trial data 9:07 a.m. Dec. 18, 2012 - MarketWatch.com
Vanda Pharma up 28% in premarket 8:29 a.m. Dec. 18, 2012 - Steve Gelsi
Vanda: progress with 24-hour-disorder drug 6:43 a.m. Oct. 15, 2012 - MarketWatch.com
Vanda to pay Lilly up to $100 mln 6:46 a.m. April 16, 2012 - MarketWatch.com
Obama’s spending plan is investors’ cue 12:01 a.m. Jan. 27, 2011 - Robert Powell
Monday’s biggest gaining and declining stocks 3:26 p.m. Nov. 15, 2010 - Robert Daniel
Wednesday's biggest gaining and declining stocks 5:13 p.m. March 10, 2010 - MarketWatch
Drug stocks pressured by J&J report; Avanir jumps 12:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Vanda Pharmaceuticals shares up 10% 8:44 a.m. Oct. 13, 2009 - Nick Godt
Vanda licenses schizophrenia drug to Novartis 2:56 a.m. Oct. 13, 2009 - Robert Daniel
Lilly and Vanda lead drug stocks south 11:41 a.m. Aug. 10, 2009 - Val Brickates Kennedy
Stocks in focus for Monday Aug. 10 6:53 p.m. Aug. 7, 2009 - MarketWatch
Drug stocks track broader market higher 12:28 p.m. May 14, 2009 - Val Brickates Kennedy
Drug stocks mixed; AstraZeneca gains on study 1:24 p.m. May 11, 2009 - Val Brickates Kennedy
Vanda, Titan rocket on drug approval 12:31 p.m. May 7, 2009 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 3:35 p.m. July 28, 2008 - MarketWatch
Vanda receives FDA not approvable letter for iloperidone 6:08 a.m. July 28, 2008 - William L. Watts
Vanda Pharma to meet with FDA to discuss decision 5:37 a.m. July 28, 2008 - Simon Kennedy

Today's Perilous Reversal Stock: Vanda Pharmaceuticals (VNDA) 9:45 a.m. Today - TheStreet.com
Medivation Q3 Loss Narrower Than Expected - Analyst Blog 9:10 a.m. Today - Zacks.com
Vanda Pharmaceuticals, Inc. (VNDA) Grabs Attention: Stock Shoots 95.9% - Tale of the Tape 8:51 a.m. Today - Zacks.com
VNDA Stock Nearly Doubles in One Day 3:49 a.m. Today - InvestorPlace.com
Barbarian At The Gate: Vanda Pharmaceuticals (VNDA) 1:23 p.m. Nov. 12, 2013 - TheStreet.com
Vanda’s Sleep Aid for the Blind Nears FDA Approval and 2 Other Hot Stocks to Watch 12:14 p.m. Nov. 12, 2013 - Wall St. Cheat Sheet
Interesting VNDA Put And Call Options For January 2016 1:42 p.m. Nov. 11, 2013 - TheStreet.com
VNDA January 2015 Options Begin Trading 11:23 a.m. Nov. 8, 2013 - TheStreet.com
10-Q: VANDA PHARMACEUTICALS INC. 6:59 a.m. Nov. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
Vanda Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 5:40 p.m. Nov. 7, 2013 - Seeking Alpha
Vanda Pharmaceuticals Inc. Discusses Q3 2013 Results (Webcast) 9:55 a.m. Nov. 7, 2013 - Seeking Alpha
A Look Back At Biotech Short Picks 2:18 p.m. Oct. 31, 2013 - Seeking Alpha
Biotechs With FDA Review Dates In November 2013 1:23 p.m. Oct. 25, 2013 - Seeking Alpha
Biotech Stock Mailbag: Vanda, Onconova, Catalyst Pharma, Sarepta 6:00 a.m. Oct. 25, 2013 - TheStreet.com
Vanda Poised For Growth Upon Approval Of Tasimelteon 4:25 p.m. Oct. 24, 2013 - Seeking Alpha
Interesting VNDA Put And Call Options For June 2014 12:10 p.m. Oct. 23, 2013 - TheStreet.com
SA Pro: Top Long And Short Ideas, Monday October 21 7:30 a.m. Oct. 22, 2013 - Seeking Alpha
Lazard Capital Markets Reiterates Buy on Vanda Pharmaceuticals on Good Entry Point 11:25 a.m. Oct. 21, 2013 - benzinga.com
Wall Street Breakfast: Must-Know News 6:32 a.m. Oct. 21, 2013 - Seeking Alpha
SA Pro: Top Long And Short Ideas, Friday October 18 7:30 a.m. Oct. 19, 2013 - Seeking Alpha

SRPT, HOLX, QUIK and VNDA added to NASDAQ Active Stock Watch List at GSR 10:21 a.m. Nov. 12, 2013 - ACCESSWIRE
WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR 10:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Vanda Pharmaceuticals Reports Third Quarter 2013 Results 6:55 a.m. Nov. 7, 2013 - PR Newswire
Returning Value to Shareholders through Dividends, Strong Financial Results, and Regulatory Approvals - Research Report on Lilly, Illumina, Regeneron, Teva, and Vanda Pharmaceuticals 7:00 a.m. Oct. 24, 2013 - PR Newswire
Vanda Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 7, 2013 6:00 p.m. Oct. 21, 2013 - PR Newswire
Vanda Pharmaceuticals Announces FDA Advisory Committee Meeting On November 14, 2013 3:01 p.m. Oct. 16, 2013 - PR Newswire
Vanda Pharmaceuticals to Present at the Stifel Nicolaus 2013 Healthcare Conference 4:00 p.m. Sept. 10, 2013 - PR Newswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA 5:42 p.m. Aug. 23, 2013 - GlobeNewswire
UPCOMING DEADLINE: Levi & Korsinsky Reminds Investors With Losses in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and of August 26, 2013 Deadline to Seek a Lead Plaintiff Position -- VNDA 11:49 a.m. Aug. 21, 2013 - GlobeNewswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA 6:15 p.m. Aug. 16, 2013 - GlobeNewswire
VANDA PHARMACEUTICALS DEADLINE ALERT: Levi & Korsinsky Notifies Investors With Losses in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 26, 2013 to Seek a Lead Plaintiff Position -- VNDA 12:06 p.m. Aug. 14, 2013 - GlobeNewswire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Vanda Pharmaceuticals Inc. of Upcoming Deadline 5:53 p.m. Aug. 12, 2013 - BusinessWire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 26, 2013 to Seek a Lead Plaintiff Position 4:00 p.m. Aug. 12, 2013 - BusinessWire
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Vanda Pharmaceuticals, Inc. to Contact the Firm -- VNDA 9:10 p.m. Aug. 9, 2013 - GlobeNewswire
Vanda Pharmaceuticals Inc. Prices Public Offering of Common Stock 7:47 a.m. Aug. 7, 2013 - PR Newswire
Vanda Pharmaceuticals Inc. Proposes Public Offering of Common Stock 3:01 p.m. Aug. 6, 2013 - PR Newswire
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position 1:34 p.m. Aug. 6, 2013 - PR Newswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA 5:50 p.m. Aug. 2, 2013 - GlobeNewswire
Expanding R&D Programs, Clinical Trials, Drug Applications and Acquisitions, Advancing to Help Patients with Unmet Medical Needs - Research Report on Questcor, BioMarin, Vanda, Illumina and Theravance 7:00 a.m. Aug. 2, 2013 - PR Newswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on AEGR, ARRY, VNDA and VRTX 7:31 a.m. July 31, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Independents Finally Center Stage on Election Night

Unprecedented Spotlight on Independent Voters The political landscape is in for a shake-up, folks. Come November 3rd, we're witnessing something that hasn't been done before—an entire Election Night dedicated exclusively to independent voters. It’s high time these folks got the spotlight, considering a whopping 45% of U.S. adults have shunned the extremist seesaw of...

2026 Diamond Certified Directory: A Trustworthy Guide

A Refreshing Reality in a Sea of Online Reviews Imagine having a compass that actually points you in the right direction through the foggy mess of online reviews. That's what the Fall 2026 Diamond Certified Directory aims to be. This ain't some random collection of opinions. This is hard-hitting, reliable information that's been battle-tested in the real world. We're...

LuminoCity Expands with B2B Entertainment Showcase

Big Lights, Immersive Action In an age where entertainment must be larger-than-life, LuminoCity seems to have figured out how to transform the ordinary into the extraordinary. The folks over at LuminoCity Festival have rolled out a strategy to supercharge their business-to-business (B2B) offerings, aiming to bring immersive entertainment solutions to parks, zoos, and...

Netcapital's 28.62% Plunge: A Fraudulent Drama Unfolds

Netcapital: The Plunge Heard 'Round the Market There it is, clear as day—Netcapital’s (NASDAQ: NCPL) stock plummeting 28.62% like a lead balloon. Shareholders had to watch in horror as pieces of their investments seemed to evaporate, all thanks to a swirl of alleged fraud. You can't just shrug off accusations that a company you've betted on has been cooking its books,...

BCG Pinpoints Fatal Ignorance in Critical Mineral Risks

Unseen Weakness in Industrial Giants Imagine staring right past a pothole while driving, then wondering why you keep popping your tires. That's where industrial companies find themselves today with critical minerals, according to a new wake-up call from Boston Consulting Group. The giant problem? Firms are blissfully unaware of the mosquitoes in their machines—tiny,...

Philips’ Beauty Tech Trends Promise Intimacy by 2027

Beauty Tech Takes a Personal Turn It's 2026, and in the beauty industry, folks are trading flashy for the intimate and intelligent. Philips, that stalwart of tech innovation, is waving the banner, revealing three beauty trends we can't ignore if we plan to keep up with the times. The Rise of Intelligent Guidance First off, everyone and their dog seems to ask how tech is...

SLM Hit by Earnings Miss: Shareholders Eye Legal Action

When A Profit Turns To Loss There's a certain sting that comes with expecting a profit only to get smacked with a loss. You know the kind—like when SLM Corporation shareholders had their expectations shattered on October 22, 2026. They figured they'd see a $0.17 profit per share, but what landed instead was a $0.19 loss. That's a $0.36-per-share swing, enough to make...

Advanced Process Solutions Reshuffles Leadership Amid Growth

Clint Johnson Ascends as VP Amidst Strategic Moves Clint Johnson's climb to Vice President of Services and Operations at Advanced Process Solutions (APS) ain't just routine corporate ladder gymnastics—it's a sign of shifting tides. Slapping your buddy’s back after years in the trenches, that kind of camaraderie translates into momentum. The precision manufacturing...

HDR: Revolutionizing Future Video Entertainment Experiences

HDR: The Unsung Hero of Video Quality Folks, let’s not kid around—high dynamic range (HDR) is no longer just the flashy chrome on the entertainment industry's Cadillac. It’s becoming the engine. Parks Associates’ recent snoop into the trends—that’s right, fresh off the presses from Plano, Texas—makes it clear: HDR is set to remake how we consume video on...

Energy Fuels Secures Key Financing for Donald Project

Donald Project: A Step Closer to Reality Look, when those rare earths start moving, the entire market gets a whiff of promise. Energy Fuels' Donald Rare Earth and Mineral Sands Project in Australia is gearing up for real action with a fresh funding nod. Export Finance Australia and the National Reconstruction Fund Corporation have conditionally greenlit up to A$180...